Testosterone Enanthate Cost in Idaho (2026): Cash Prices, Insurance, and Savings Options

What Does Testosterone Enanthate Actually Cost in Idaho Right Now?

Idaho residents filling a testosterone enanthate prescription without insurance pay roughly $70 per month at retail chain pharmacies in 2026, based on aggregated cash-price data across the state. That figure covers a standard once-weekly intramuscular injection regimen at doses between 100 mg and 200 mg, the range most prescribers use for male hypogonadism per Endocrine Society 2018 guidelines.

The manufacturer list price for branded testosterone enanthate products sits near $120 per month. Few patients actually pay that figure. Generic versions of testosterone enanthate have been available for years, and generic competition is the single biggest reason Idaho cash prices sit well below list. A 5 mL vial of 200 mg/mL testosterone enanthate (enough for roughly 4 to 5 weekly injections depending on dose) can be found at Idaho Walmart, Walgreens, and Albertsons pharmacy locations for between $40 and $90 without any coupon, though prices fluctuate by location and month.

Compounded testosterone enanthate from Idaho-licensed 503A pharmacies costs approximately $80 per month. That may seem counterintuitive since compounding is sometimes marketed as the "cheaper" route. In Idaho, the price difference between compounded and generic retail is narrow enough that convenience or formulation preference (concentration, carrier oil) drives the choice more than savings alone.

Needle and syringe costs add $5 to $15 per month depending on source. Some pharmacies bundle supplies with the prescription; others charge separately. The FDA-approved labeling for testosterone enanthate specifies intramuscular administration, so injection supplies are a recurring line item patients should budget for.

Does Idaho Medicaid Cover Testosterone Enanthate?

No. Idaho Medicaid does not cover testosterone enanthate as of 2026. Patients enrolled in Idaho Medicaid who have a clinical diagnosis of male hypogonadism (ICD-10 E29.1) will need to explore alternative payment paths for this specific medication.

This coverage gap is not unique to Idaho. Several state Medicaid programs exclude testosterone replacement therapy entirely or impose prior authorization barriers that function as de facto exclusions. The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic hypogonadism confirmed by at least two morning total testosterone levels below 300 ng/dL, yet Medicaid formulary inclusion varies state by state regardless of guideline strength.

For Idaho Medicaid enrollees, practical options include: applying for manufacturer patient assistance programs (Endo Pharmaceuticals offers one for Delatestryl), using pharmacy discount cards that bring generic cash prices to $30 to $50 in some cases, or asking a prescriber about testosterone cypionate, which has a nearly identical clinical profile and occasionally appears on formularies that exclude enanthate. The T-Trials (NEJM 2016, N=790) used testosterone gel rather than injectable enanthate, but the findings on symptomatic benefit in older hypogonadal men apply broadly across formulations and underscore why access matters clinically.

Which Private Insurance Plans Cover Testosterone Enanthate in Idaho?

Most commercial health insurance plans sold on the Idaho exchange or through employer groups do cover generic testosterone enanthate, though prior authorization requirements are common. Blue Cross of Idaho, SelectHealth, PacificSource, and Regence BlueShield of Idaho all include injectable testosterone esters on their formularies, typically at Tier 2 (preferred generic) or Tier 3 (non-preferred generic) levels.

Prior authorization usually requires documentation of two serum total testosterone levels drawn before 10 AM showing values below 300 ng/dL, plus clinical symptoms consistent with hypogonadism. Some plans also require an LH and FSH measurement to distinguish primary from secondary hypogonadism before approval.

Copay amounts vary. On a typical Idaho employer plan with a $15/$30/$50 tier structure, generic testosterone enanthate lands in the $15 to $30 range per fill. High-deductible health plans (HDHPs) paired with HSAs are increasingly popular in Idaho. On those plans, patients pay full cash price until the deductible is met, making discount card strategies relevant even for insured patients during Q1 each calendar year.

A 2020 analysis published in the Journal of the Endocrine Society found that prior authorization denials for testosterone therapy were overturned on appeal in approximately 60% of cases when complete documentation was submitted. If your Idaho insurer denies coverage, appealing with full lab records and a letter of medical necessity from your prescribing physician is worth the effort.

Is Compounded Testosterone Enanthate Legal in Idaho?

Yes. Compounded testosterone enanthate is legal in Idaho when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Idaho follows the federal framework established by the Drug Quality and Security Act of 2013, which distinguishes between 503A (patient-specific) and 503B (outsourcing facility) compounding.

A 503A pharmacy in Idaho compounds testosterone enanthate for an individual patient based on a prescriber's order. The pharmacy must be licensed by the Idaho Board of Pharmacy and comply with USP 797 sterile compounding standards. Idaho does not have additional state-level restrictions beyond the federal framework that would limit access to compounded testosterone.

Why would a patient choose compounded over manufactured? Three reasons appear most often. First, concentration flexibility: commercial testosterone enanthate comes in 200 mg/mL, but some patients (particularly those on lower doses or subcutaneous protocols) prefer 100 mg/mL or 150 mg/mL concentrations. Second, carrier oil choice: patients with sensitivities to sesame oil (the standard carrier in Delatestryl) can request compounded versions in grapeseed or cottonseed oil. Third, multi-dose vial sizing that better matches their prescribed volume over a treatment cycle.

The FDA's guidance on compounding emphasizes that compounded drugs are not FDA-approved and do not undergo the same premarket review as manufactured products. Patients choosing compounded testosterone should verify their pharmacy's accreditation status, ideally through PCAB (Pharmacy Compounding Accreditation Board) or state inspection records.

Can You Get Testosterone Enanthate via Telehealth in Idaho?

Yes. Idaho permits telehealth prescribing of testosterone enanthate, including for initial evaluations. The state updated its telehealth parity statutes through Idaho Code § 54-5707, which allows licensed physicians and advanced practice providers to establish a patient-provider relationship via synchronous video visit.

This is significant for Idaho residents in rural areas. Roughly 35% of Idaho's population lives in counties classified as rural by the U.S. Census Bureau, and endocrinologist density outside the Boise-Meridian-Nampa corridor is thin. Telehealth platforms, including HealthRX, allow patients in Twin Falls, Idaho Falls, Pocatello, Coeur d'Alene, and smaller communities to access hormone evaluations without a multi-hour drive.

The clinical workflow for telehealth TRT prescribing typically follows this sequence: a video consultation with a licensed provider, lab orders sent to a local draw site (Quest and Labcorp both operate Idaho locations), review of results confirming hypogonadism per Endocrine Society criteria, prescription issuance, and pharmacy fulfillment either locally or via mail-order. Follow-up labs (total testosterone trough, hematocrit, PSA) are recommended at 3 months, 6 months, and annually thereafter.

One consideration: testosterone enanthate is a Schedule III controlled substance under both federal and Idaho state law. Idaho's Board of Pharmacy requires that the prescribing provider be licensed in Idaho or hold an Idaho-recognized license through interstate compact. Telehealth platforms operating in Idaho must comply with this requirement, so patients should confirm their provider's Idaho licensure before starting treatment.

How to Find the Lowest Testosterone Enanthate Price in Idaho

Getting the best price requires a strategy, not just a coupon code. Here is a concrete approach.

Step 1: Check generic availability first. Generic testosterone enanthate from manufacturers like Hikma, Perrigo, and Sun Pharma is widely stocked at Idaho pharmacies. Always ask the pharmacist to fill generic unless your prescriber specifies "dispense as written."

Step 2: Compare at least three pharmacies. Cash prices for the same generic NDC vary by 40% or more across Idaho pharmacies in the same city. Costco pharmacies (you do not need a membership to use the pharmacy in Idaho) consistently rank among the lowest-cost options for generic injectables nationwide. The FDA's Orange Book lists all approved generic testosterone enanthate products with their therapeutic equivalence ratings.

Step 3: Use a discount card strategically. GoodRx, RxSaver, and manufacturer-specific cards can bring a 5 mL vial below $40 at select Idaho locations. These work at checkout and are compatible with most pharmacies. They are not insurance and cannot be combined with Medicaid or Medicare Part D, but for cash-pay patients they often beat the pharmacy's standard retail price.

Step 4: Evaluate 90-day fills. Some Idaho pharmacies (particularly mail-order options) offer a per-unit discount on 90-day supplies. Since testosterone enanthate is a controlled substance, the maximum dispensed quantity may be limited to a 90-day supply per Idaho Board of Pharmacy regulations. Larger fills mean fewer dispensing fees.

Step 5: Ask about vial size. A 5 mL vial (1,000 mg total) costs less per milligram than a 1 mL vial (200 mg total). If your prescribed dose allows you to use a multi-dose vial within the 28-day beyond-use date per USP 797 standards, the larger vial is more economical.

A study in the Journal of Urology (2017) reported that out-of-pocket costs were the leading reason men discontinued TRT within the first year, reinforcing why price optimization is a clinical priority, not just a financial one.

What About Savings Cards and Patient Assistance Programs?

Manufacturer savings cards for testosterone enanthate exist but are less aggressively marketed than those for newer branded drugs. Endo Pharmaceuticals has periodically offered copay assistance for Delatestryl, though availability fluctuates.

The more reliable discount path for most Idaho patients is a pharmacy benefit card from GoodRx, SingleCare, or a similar aggregator. These cards negotiate pre-set rates with pharmacy benefit managers and pass a discounted price to the patient at the counter. In Idaho, GoodRx prices for a 5 mL vial of generic testosterone enanthate 200 mg/mL range from approximately $35 to $75 depending on pharmacy, as of May 2026. That often beats the pharmacy's own cash price.

For uninsured patients who meet income thresholds, NeedyMeds and RxAssist maintain databases of patient assistance programs. These programs typically require proof of income below 200% to 400% of the federal poverty level, a valid prescription, and U.S. residency. Processing takes 4 to 6 weeks, so they are best pursued as a long-term strategy rather than an immediate fix.

Idaho-specific resources include the Idaho Health Insurance Exchange (Your Health Idaho) open enrollment period from November through mid-January, where qualifying individuals may obtain commercial coverage with testosterone enanthate formulary inclusion at subsidized premium rates. Outside open enrollment, qualifying life events (job loss, relocation, marriage) open special enrollment windows.

How Does Idaho Compare to Neighboring States on TRT Costs?

Idaho's $70 average monthly cash price for testosterone enanthate sits in the middle range for the Mountain West. Montana and Wyoming average $65 to $75. Oregon and Washington, with larger pharmacy networks and more competitive pricing, average $55 to $65. Utah averages $60 to $70.

The meaningful differentiator is not pharmacy pricing but Medicaid policy. Oregon Medicaid covers testosterone enanthate for diagnosed hypogonadism. Washington's Apple Health program includes it with prior authorization. Idaho's exclusion creates a coverage gap that affects low-income patients disproportionately.

The Endocrine Society's 2018 guideline notes that untreated symptomatic hypogonadism is associated with reduced bone mineral density, decreased lean mass, increased visceral adiposity, depressive symptoms, and sexual dysfunction. Dr. Shalender Bhasin, the guideline's lead author, stated: "Testosterone treatment of older men with low testosterone concentrations and symptoms suggestive of androgen deficiency improved sexual function, physical function, and mood." The clinical stakes of treatment access are not trivial.

In the T-Trials (Snyder et al., NEJM 2016, N=790), men aged 65 and older with testosterone levels below 275 ng/dL who received testosterone gel for 12 months showed significant improvements in sexual activity, walking distance, and mood compared to placebo. While that trial used topical gel, the testosterone enanthate injection achieves equivalent serum levels when dosed appropriately, and injectable formulations cost substantially less than branded gels, making them the practical first-line choice for cost-conscious patients in states like Idaho where coverage gaps exist.

The American Urological Association's 2018 guideline on testosterone deficiency recommends that clinicians "inform testosterone deficient patients of the availability of testosterone therapy, its potential benefits, and its risks" regardless of insurance status. Access should not depend on ZIP code, yet for Idaho Medicaid recipients, it effectively does.

Monitoring Costs Beyond the Prescription

Testosterone enanthate is not a standalone expense. Responsible TRT requires periodic lab monitoring, and those costs add up.

Baseline labs before starting therapy typically include: total testosterone (two morning draws), free testosterone, LH, FSH, complete blood count (CBC) with hematocrit, comprehensive metabolic panel, lipid panel, and PSA for men over 40. This panel runs $150 to $350 without insurance at Idaho draw sites. With insurance, copays for lab work range from $0 (many plans cover preventive labs at no cost) to $50.

Follow-up monitoring recommended by the Endocrine Society includes testosterone trough levels and hematocrit at 3 months, 6 months, and 12 months after initiation, then annually. Hematocrit monitoring is non-negotiable. Testosterone stimulates erythropoiesis, and hematocrit values exceeding 54% require dose reduction or temporary cessation per guideline recommendations due to increased thrombotic risk. A 2019 pharmacovigilance review in JAMA Internal Medicine found that polycythemia was the most commonly reported adverse event in men on injectable testosterone esters.

Direct-to-consumer lab services (Quest Direct, Labcorp OnDemand) operate in Idaho and offer testosterone and CBC panels for $50 to $100, often cheaper than facility-based draws for uninsured patients.

Annualized, the full cost of testosterone enanthate therapy in Idaho for an uninsured cash-pay patient breaks down roughly as follows: medication at $840 per year, supplies at $60 to $120, labs at $200 to $500, and provider visits (2 to 4 annually) at $150 to $400 via telehealth. Total annual cost: approximately $1,250 to $1,860. For insured patients with formulary coverage, the annual out-of-pocket total drops to $400 to $800 depending on plan structure.